Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688639 vs VRTX, REGN, MRNA: Days Payable Comparison
For the Biotechnology subindustry, Anhui Huaheng Biotechnology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anhui Huaheng Biotechnology Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Anhui Huaheng Biotechnology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Anhui Huaheng Biotechnology Co's Days Payable falls into.
Anhui Huaheng Biotechnology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anhui Huaheng Biotechnology Co (SHSE:688639) has a Days Payable of 84.03 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Anhui Huaheng Biotechnology Co and its competitors. This is near median its historical median of 86.69. Over the past decade, Anhui Huaheng Biotechnology Co's Days Payable has ranged from 52.78 to 128.69. According to the industry distribution chart, Anhui Huaheng Biotechnology Co ranks #380 out of 708 companies in the Biotechnology industry, placing it in the top 53.7%.
Is Anhui Huaheng Biotechnology Co's Days Payable too high?
Anhui Huaheng Biotechnology Co's current Days Payable of 84.03 is near median its 10-year median of 86.69. Over the past 10 years, this metric has ranged from a low of 52.78 to a high of 128.69. The Biotechnology industry median Days Payable is 111.17. Anhui Huaheng Biotechnology Co's value of 84.03 is 24.4% below this industry median. Based on the distribution chart, Anhui Huaheng Biotechnology Co ranks #380 out of 708 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Anhui Huaheng Biotechnology Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Anhui Huaheng Biotechnology Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anhui Huaheng Biotechnology Co ranks #380 out of 708 companies for Days Payable. This places Anhui Huaheng Biotechnology Co in the lower half of its industry. The industry median Days Payable is 111.17. Anhui Huaheng Biotechnology Co's value of 84.03 is 24.4% below this benchmark. Historically, Anhui Huaheng Biotechnology Co's own Days Payable has ranged from 52.78 to 128.69 over the past decade. While the company's 10-year median is 86.69 vs. the industry median of 111.17, Anhui Huaheng Biotechnology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 111.17, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anhui Huaheng Biotechnology Co's current Days Payable of 84.03 is 24.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Anhui Huaheng Biotechnology Co and its competitors. For the Biotechnology industry, the median Days Payable is 111.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anhui Huaheng Biotechnology Co's current Days Payable is 84.03, which is near median its own 10-year median of 86.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anhui Huaheng Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Anhui Huaheng Biotechnology Co (SHSE:688639) is currently considered Possible Value Trap. The stock's GF Value™ is ¥42.45, compared to a current price of ¥17.61 — trading 58.5% below its estimated fair value. The current Days Payable is 84.03, which is near median its 10-year median of 86.69 and 24.4% below the Biotechnology industry median of 111.17. Anhui Huaheng Biotechnology Co's overall GF Score™ is 75/100 with 13 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Anhui Huaheng Biotechnology Co (SHSE:688639), the current Days Payable is 84.03 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Anhui Huaheng Biotechnology Co (SHSE:688639) Overvalued in 2026?
Based on GuruFocus' analysis, Anhui Huaheng Biotechnology Co stock appears to be undervalued.
The current stock price of ¥17.61 is trading 58.5% below its estimated GF Value™ of ¥42.45.
GuruFocus considers Anhui Huaheng Biotechnology Co to be Possible Value Trap.
Key valuation signals for SHSE:688639:
Days Payable: 84.03 (near median its 10-year median of 86.69)
GF Value™: ¥42.45 vs. price of ¥17.61 (58.5% below fair value)
Industry Position: 24.4% below the Biotechnology median (#380 of 708)
No single metric tells the full story. See the SHSE:688639 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Anhui Huaheng Biotechnology Co Ltd is engaged in the research and development, production and sales of bio-based products such as amino acids and other alanine products.
75GF Score
Get the complete analysis for SHSE:688639
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688639 has been successfully added to your 
